NIH Hid Public Comments Package — page 116

(C] Polimeni, (NIH/OD) Senior Attorney Office of the General Counsel Public Health Division, NIH Branch (direct) @nih.gov This e-mail message is intended for the exclusive use of the recipient(s) named above. It may contain information that is protected, privileged, or confidential, and it should not be disseminated, distributed, or copied to persons not authorized to receive such information. If you are not the intended recipient, any dissemination, distribution, or copying is strictly prohibited. If you think you have received this e-mail message in error, please notify the sender immediately. From: Imhoff, Sarah (NIH/OD) [E] < @nih.gov> Sent: Wednesday, November 10, 2021 3:30 PM To: Fine, Amanda (NIH/OD) [E] < @nih.gov>; Prince, Scott (NIH/OD) [E] < @nih.gov>; Polimeni, Lydia (NIH/OD) [E] < @nih.gov>; Kern, Anna (NIH/OD) [C] < @nih.gov>; Lankford, David (NIH/OD) [E] < @od31tm1.od.nih.gov> Subject: Call Regarding Update on NIH Facebook/Instagram Lawsuit Hi everyone, David Lankford and I would like to schedule a call with you to give an update on our discussions with the DOJ this week, some additional questions we have and your initial thoughts on DOJ's current proposed next steps. We haven't received any firm advice on what NIH should do moving forward yet, but wanted to get your opinion on DOJ's current next steps to see whether we should have further discussions with them about their proposed strategy. Can you please let me know when your team is available for a discussion this Friday, 11/12? We are open except from 34pm. Thank you, Sarah J. Imhoff, JD, MHSA Senior Attorney Office of the General Counsel Public Health Division, NIH Branch (direct) @nih.gov This e-mail message is intended for the exclusive use of the recipient(s) named above. It may contain information that is protected, privileged, or confidential, and it should not be disseminated, distributed, or copied to persons not authorized to receive such information. If you are not the intended recipient, any dissemination, distribution, or copying is strictly prohibited. If you think you have received this e-mail message in error, please notify the sender immediately.